News Daily News Long-term Evolocumab Safe, Effective for Familial Hypercholesterolemia Treatment Yael L. Maxwell February 12, 2020
News Daily News Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds Michael O'Riordan February 06, 2020
News Daily News Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol Yael L. Maxwell January 28, 2020
News Daily News Pot Talk: Review Urges Cardiologists to Discuss Marijuana Use L.A. McKeown January 21, 2020
News Daily News Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL Michael O'Riordan January 17, 2020
News Daily News Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes Michael O'Riordan January 14, 2020
News Daily News Most Secondary Prevention Patients Are Eligible for Multiple Drugs Michael O'Riordan January 03, 2020
News Daily News Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019 Yael L. Maxwell December 20, 2019
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Daily News Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk Michael O'Riordan December 03, 2019
News Conference News AHA 2019 Inclisiran in FH: Safe, Cuts LDL in This Challenging Group Yael L. Maxwell November 19, 2019
News Conference News AHA 2019 Inclisiran Slashes LDL in ASCVD Patients: ORION-10 Yael L. Maxwell November 16, 2019
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Conference News AHA 2019 LDL Levels Still Too High in Many Statin-Treated Patients: PINNACLE Michael O'Riordan November 13, 2019
News Daily News Lipid Levels Declining in US, With Drops Seen After 2013 Guideline Release Michael O'Riordan November 11, 2019
News Daily News Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most Yael L. Maxwell November 07, 2019
News Daily News Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD Michael O'Riordan November 05, 2019
News Daily News Evolocumab Safe and Effective Out to 5 Years: OSLER-1 Yael L. Maxwell October 22, 2019
News Daily News New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients Michael O'Riordan October 22, 2019
News Daily News Statins Started in Kids With FH Provide Benefits in Adulthood Yael L. Maxwell October 17, 2019